Results 221 to 230 of about 18,093,548 (300)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Enhancing g‐C3N4 Photocatalytic Activity: K‐Doping and CuO Heterojunction for Selective CO2 Conversion to CH4

open access: yesElectron, EarlyView.
The CuO/K‐g‐C3N4 heterostructure photocatalyst achieves selective CO2 reduction to CH4 (93.03% selectivity) under visible‐light irradiation. K‐doping enhances crystallinity, whereas CuO forms a p‐n heterojunction to promote charge separation and electron transfer.
Ahmed Ismail   +8 more
wiley   +1 more source

Genetic testing among patients evaluated for epilepsy surgery

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective Genetic testing performed to identify the underlying etiology of epilepsy has become increasingly common and is now being recommended as part of the presurgical evaluation for epilepsy surgery. This study aimed to characterize the types of genetic tests performed in patients evaluated for epilepsy surgery and assess how genetic ...
Anni Saarela   +7 more
wiley   +1 more source

Core outcome set for quality of life of family caregivers of adults with epilepsy: A Delphi consensus study

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective Epilepsy significantly affects daily functioning and health‐related quality of life (HRQOL) of those living with the condition. Less is known about HRQOL of family caregivers of adults with epilepsy, yet the functioning of patients and caregivers is interlinked, and caregivers' unmet support needs are high.
Florien Boele   +10 more
wiley   +1 more source

Perils and progress in epilepsy surgery utilization: Twenty‐five years later

open access: yesEpilepsia, EarlyView.
Abstract More than 25 years have passed since the first randomized controlled trial (RCT) established that surgery is superior to continued anti‐seizure medication (ASM) for drug‐resistant temporal lobe epilepsy, and nearly as long since a joint practice parameter urged that appropriate surgical candidates be referred to a specialized center for ...
Dario J. Englot
wiley   +1 more source

Home - About - Disclaimer - Privacy